A Chinese biologics technology platform company offering end-to-end solutions for drug discovery, development, and manufacturing.
AI-generated insights about Wuxi Biologics (Cayman) Inc. from various financial sources
Stock dropped significantly by 4.8% due to escalating U.S.-China trade tensions, highlighting the pharmaceutical sector's volatility and risk during such periods.
Stock dropped significantly by 4.8% due to escalating U.S.-China trade tensions, highlighting the pharmaceutical sector's volatility and risk during such periods.